Clinical Trials Logo

Clinical Trial Summary

This is a phase 1, single-center, randomized, double-blind, placebo-controlled, dose-escalation clinical trial of single and multiple intravenous doses of TNP-2092 for injection in healthy Chinese participants.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06394518
Study type Interventional
Source TenNor Therapeutics Inc.
Contact
Status Completed
Phase Phase 1
Start date July 7, 2022
Completion date February 24, 2023

See also
  Status Clinical Trial Phase
Not yet recruiting NCT03732365 - Phase 2 Randomized Study to Compare Ultrasonic Drug Delivery to Standard of Care for the Treatment of Infections in Non-Healing Wounds Phase 2